Next Article in Journal
Brainstem Glioma Prognostication: Static FET PET/CT
Previous Article in Journal
Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan
Previous Article in Special Issue
Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study on 285 Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk

1
Section of Dermatology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
2
Dermatology and Venereology, Ordine Mauriziano “Umberto I” Hospital, 10128 Turin, Italy
3
Department of Medical Sciences, University of Turin and CPO-Piemonte, 10121 Turin, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2025, 17(18), 3064; https://doi.org/10.3390/cancers17183064
Submission received: 23 August 2025 / Revised: 16 September 2025 / Accepted: 18 September 2025 / Published: 19 September 2025
(This article belongs to the Special Issue Dermoscopy in Skin Cancer)

Simple Summary

The diagnosis of melanoma on the trunk represents a significant clinical challenge. Benign nevi in this location are subject to mechanical stress, which can induce atypical features and lead to a high rate of precautionary excisions. This study aimed to identify more reliable diagnostic signs for this specific body area. We analyzed 321 melanocytic lesions (227 nevi and 94 melanomas) on the trunk, evaluating several dermoscopic features. We specifically investigated a new concept: whether a lesion’s growth direction relative to the skin’s natural tension lines could distinguish benign from malignant lesions. Our findings show that benign nevi tend to align with these lines, while melanomas grow in a disorganized manner. This simple visual feature may be a powerful predictor of melanoma. This discovery could provide clinicians with a valuable new tool to improve diagnostic accuracy, helping to detect melanomas earlier and reduce unnecessary surgical procedures on the trunk.

Abstract

Background/Objectives: The diagnosis of melanocytic lesions on the trunk is challenging due to a high frequency of atypical features in benign nevi, leading to a high rate of unnecessary excisions. This study aimed to identify robust dermoscopic predictors of cutaneous melanoma on the trunk and to evaluate a novel diagnostic criterion: the orientation of lesions relative to Langer’s skin tension lines. Methods: We conducted a retrospective analysis of 321 melanocytic lesions (227 nevi and 94 melanomas) excised from the trunk. Dermoscopic features were systematically evaluated. A chi-square test and an age- and sex-adjusted multivariate logistic regression were performed to calculate odds ratios (OR) and identify independent predictors of malignancy. A subgroup analysis was also conducted on “critical” versus “non-critical” anatomical sites. Results: Non-adherence to Langer’s lines was the most powerful predictor of melanoma (OR 5.55, 95% CI 3.22–9.81; p < 0.001). Other significant predictors included blue-white veil (OR 5.09) and polymorphous vessels (OR 4.06). Notably, 70% of melanomas did not align with Langer’s lines, whereas 72% of nevi did. Classic features such as scar-like regression were not statistically significant predictors in this cohort. In the subgroup analysis, color asymmetry was a significant predictor of melanoma only in non-critical sites (p for interaction = 0.026). Conclusions: The orientation of a melanocytic lesion relative to Langer’s lines is a powerful and independent predictor of melanoma on the trunk. This simple morphological feature, which may reflect differences in growth patterns between malignant and benign lesions, could serve as an additional clinical cue to support decision-making and improve diagnostic accuracy in this challenging anatomical location.

1. Introduction

Cutaneous melanoma (CM) represents a significant global health burden, with rising incidence globally. While it represents a minority of skin cancer cases, it is responsible for the majority of skin cancer-related deaths [1]. The prognosis of CM is excellent when diagnosed at an early stage, with 5-year survival rates >99% for localized disease, but drops sharply once metastasis occurs, highlighting the importance of a timely diagnosis [2]. Over the past three decades, dermoscopy has become the standard of care for the evaluation of skin lesions, significantly improving diagnostic accuracy [3,4]. The implementation of systematic algorithms has further refined the diagnostic process [5]. Despite these advances, the diagnostic specificity for melanoma remains suboptimal. This is reflected in the NNE—the number of benign lesions surgically removed to diagnose one melanoma—which can range from 2.2 to over 280 in general practice, indicating a substantial overtreatment [6,7]. A key challenge in dermoscopy is that the morphology of melanocytic lesions is highly dependent on their anatomical location. Well-established “special sites,” such as the face, palms and soles, and nails, exhibit unique dermoscopic patterns with site-specific diagnostic criteria [8,9]. The trunk is the most common location for melanoma, particularly in fair-skinned populations, and it presents its own distinct diagnostic challenges [10]. Mechanical stress and friction can induce atypical features in otherwise benign nevi, mimicking CM, while age further modulates risk, with the trunk representing a frequent site in younger patients [11,12,13]. This ambiguity may contribute to a high rate of excisions and diagnostic ambiguity. An underexplored aspect is the influence of skin biomechanics on lesion morphology. Langer’s lines (Figure 1), which map the direction of minimal skin tension, are fundamental to surgical practice for optimizing cosmetic outcomes but are seldom considered in a diagnostic context [14,15]. A pivotal observation suggested that benign acquired nevi on the back tend to align their major axis with Langer’s lines, presumably due to their slow, indolent growth being influenced by the surrounding dermal collagen architecture [16]. By contrast, we hypothesized that the rapid and disorganized proliferation of CM would not be constrained by these tension lines, causing the lesion to grow in a random orientation. Therefore, the primary aim of this study was twofold: first, to conduct a comprehensive analysis of dermoscopic features of melanocytic lesions on the trunk to identify robust predictors of malignancy in this specific location, and second, to evaluate the orientation of lesions relative to Langer’s lines, considered here as a novel clinical parameter with potential diagnostic relevance.

2. Materials and Methods

This study was conducted through a retrospective analysis of clinical and dermoscopic images obtained from a database of skin lesions excised from patients who attended the videodermatoscopy service at the Dermatologic Clinic of the Turin University Hospital, Italy, between 2021 and 2024. The initial database comprised nearly 2100 excised lesions, for which a histopathological diagnosis was obtained. After excluding atypical Spitz tumors due to their uncertain biological nature and diagnostic ambiguity, and cases with missing histopathological reports, incomplete or low-quality clinical or dermoscopic imaging, or incorrect patient data, a total of 338 excisions on the trunk due to clinical suspicion of CM were identified. From this cohort, we selected all melanocytic nevi and CM located on the trunk. The final study population consisted of 227 melanocytic nevi and 94 CM. Clinical and dermoscopic images were acquired using two digital dermoscopy systems: Fotofinder Medicam 1000 (FotoFinder Systems GmbH, Bad Birnbach, Germany) and Vidix 4.0 (Canfield Scientific Inc., Parsippany, NJ, USA). Images were captured in polarized light mode at 10× magnification. All patient data were retrieved from the hospital’s records and subsequently stored in an internal computerized database. For a more detailed topographical analysis, the trunk was subdivided into nine distinct areas: pectoral, sternal/parasternal, abdominal, flank, shoulder, scapular, interscapular, dorsal, and lumbar regions. The Number Needed to Excise (NNE) was defined as the ratio between the total number of lesions excised on suspicion of CM and the number of histologically confirmed melanomas. NNE was calculated separately for lesions located on the trunk and for all other anatomical sites (excluding nails, scalp, and mucosal surfaces). For the study analysis, we gathered histopathological data from the pathology reports, including Breslow thickness and the maximum recorded horizontal dimensions. Each lesion was evaluated for a set of predefined dermoscopic parameters based on the established literature [17,18]. All variables were assessed dichotomously (present or absent), except for the number of colors, which was recorded as a quantitative measure. Each lesion was independently assessed by two dermoscopists with ≥4 years of experience, with arbitration by a senior expert in uncertain cases. Lesion borders were categorized as either faded or sharp, while asymmetry was assessed in terms of both pattern and color. Color evaluation included the total number of distinct colors, as well as the presence of gray. Dermoscopic structures were systematically examined for atypical blotches, hypopigmented structureless areas, atypical network, blue-white veil, scar-like regression, peppering, asymmetric or irregular globules and dots, pseudopods and radial streaks, polymorphous vessels, shiny white structures (white lines), angulated lines, prominent skin markings, and negative (inverse) network. The global dermoscopic pattern of each lesion was further classified as globular, reticular, homogeneous, multicomponent, or non-specific, the latter including featureless, structureless, or feature-poor lesions. When available, digital monitoring data were incorporated to document atypical or asymmetric growth. Lesion orientation was determined by evaluating the alignment of the lesion’s major axis relative to Langer’s lines, which represent the predominant skin tension lines of the anatomical site. For round or symmetrical lesions in which no preferential axis could be established, orientation was conventionally considered parallel to Langer’s lines to ensure consistency of classification. Data were compiled into a dedicated database for statistical analysis. A chi-square (χ2) test was used to identify statistically significant differences (p-value < 0.05) between nevi and CM for the analyzed variables. Subsequently, a multivariate logistic regression, adjusted for age and sex, was performed for all variables with more than ten occurrences to calculate odds ratios (OR) and their corresponding 95% confidence intervals (CI). A site-specific analysis was also conducted by stratifying the trunk into “critical” areas that were areas subject to greater mechanical stress and tension from upper limb movement (interscapular, scapular, pectoral, and sternal/parasternal) and “non-critical” areas (shoulder, abdomen, dorsal, lumbar, and flank). The p-value for interaction was calculated to assess whether the risk associated with each parameter differed significantly between these two subgroups. All analyses were performed using R software (Version 4.4.0 Puppy Cup, released on 24 April 2024).

3. Results

3.1. Number Needed to Excise (NNE)

A total of 338 excisions were performed in the trunk due to clinical suspicion of CM. Histopathological analysis confirmed 94 melanomas, 227 benign melanocytic nevi, and 17 other non-melanocytic lesions. Based on these data, the NNE for trunk lesions was calculated as 3.6. In comparison, for all other anatomical sites (excluding nails, scalp, and mucosal surfaces), 377 lesions were excised, including 189 CM, corresponding to an NNE of 2.0.

3.2. Population Characteristics and Lesion Sites

A total of 321 melanocytic lesions were included in the study (227 nevi; 94 CM). The mean age in the nevus group was 51.3 years (SD 15.1), while the mean age for patients in the melanoma group was 61.5 years (SD 14.7). The mean largest horizontal diameter of lesions was 6.2 mm (SD 2.6 mm) for nevi and 9.6 mm (SD 5.4 mm) for CM. Within the melanoma group, the mean Breslow thickness was 0.4 mm (SD 0.9 mm), with a total of 50 in situ melanomas (53.2%). Regarding patient sex, no significant difference in incidence was noted for CM (52% male, 48% female). In contrast, a higher percentage of excised nevi on the trunk occurred in males (63%) compared to females (37%). The anatomical distribution of lesions is shown in Table 1.

3.3. Frequencies of Dermoscopic Features and Adherence to Langer’s Lines in Trunk Nevi and Melanomas

The prevalence of 21 pre-defined dermoscopic features was systematically evaluated in both benign and malignant lesions, and the findings are detailed in Table 2. Several features traditionally considered hallmarks of melanoma were observed at high frequencies in both groups. For instance, an atypical network was present in 79% of melanomas but was also a common finding in 64% of benign nevi. Similarly, structureless areas were identified in 85% of melanomas and 64% of nevi. Irregular globules or dots were identified in 57% of nevi versus only 34% of melanomas. Likewise, radial streaks were present in 32% of nevi compared to 16% of melanomas.

3.4. Predictors of Melanoma on the Trunk

To identify independent predictors of malignancy, an age- and sex-adjusted logistic regression analysis was performed (Table 3). After adjustment, features significantly associated with an increased likelihood of melanoma included non-adherence to Langer’s lines (OR 5.55, 95% CI 3.22–9.81; p < 0.001), hypopigmented structureless areas (OR 3.05, 95% CI 1.61–6.13; p < 0.001), blue-white veil (OR 5.09, 95% CI 2.26 12.04; p < 0.001), and polymorphous vessels (OR 4.06, 95% CI 1.67–10.19; p = 0.002). Conversely, in our cohort, the analysis identified features predictive of a benign diagnosis. The presence of a globular pattern (OR 0.24, 95% CI 0.07–0.63; p = 0.004) and irregular globules or dots (OR 0.46, 95% CI 0.27–0.78; p = 0.004) was significantly associated with a benign diagnosis.

3.5. Lesion Orientation Relative to Langer’s Lines in CM vs. Nevi

The orientation of the lesion’s main axis relative to Langer’s lines was evaluated. Overall, 72% (163/227) of benign nevi were oriented parallel to Langer’s lines, whereas 70% (66/94) of melanomas were not (Figure 2). A melanocytic lesion on the trunk that was not oriented along Langer’s lines had over five times the odds of being a CM compared to an aligned lesion (OR 5.55, 95% CI 3.22–9.81; p < 0.001).

3.6. Subgroup Analysis by Anatomic Location: “Critical” vs. “Non-Critical” Sites

A subgroup analysis was conducted by dividing the trunk into “critical” sites (scapular, interscapular, pectoral, sternal/parasternal) and “non-critical” sites (shoulder, abdomen, dorsal, lumbar, flank). Most dermoscopic predictors demonstrated a consistent effect across both subgroups. Non-adherence to Langer’s lines was a significant predictor of melanoma in both critical (OR 5.29, 95% CI 2.43–12.16; p < 0.001) and non-critical (OR 6.04, 95% CI 2.72–14.14; p < 0.001) areas. Features predictive of nevi, such as the globular pattern and radial streaks, also retained their significant association in both subgroups (Table 4). A statistically significant interaction was found for asymmetry of color (p for interaction = 0.026). In non-critical sites, color asymmetry was a significant predictor of melanoma (OR 2.27, 95% CI 1.06–5.02; p = 0.035). In critical sites, color asymmetry was not associated with malignancy (OR 0.63, 95% CI 0.29–1.35; p = 0.234).

4. Discussion

The differential diagnosis of melanocytic lesions on the trunk represents a significant daily challenge for dermatologists, an opinion corroborated by the findings of this study. Our data reveal an NNE of 3.6 for the trunk, a figure markedly higher than the 2.0 for all other anatomical sites combined, confirming that truncal lesions are more frequently excised for histopathological assessment. This low NNE reflects the nature of our database, which includes only lesions referred for second-level evaluation, thus representing a preselected population. However, the relatively higher NNE for truncal lesions, in our cohort, quantifies a site-specific diagnostic uncertainty that persists even within a specialist setting and aligns with the broader clinical challenge reflected in the literature [6,7]. To further characterize this diagnostic uncertainty, we analyzed the prevalence of 21 predefined dermoscopic features in both benign and malignant truncal lesions (Table 2). Several features classically considered hallmarks of melanoma were detected at unexpectedly high frequencies in nevi [4,17,19]. For example, an atypical network was observed in 79% of melanomas but also in 64% of nevi, and hypopigmented structureless areas were present in 85% of melanomas and 64% of nevi. Moreover, dermoscopic features such as irregular globules/dots and radial streaks—observed in melanomas but also in growing or dysplastic nevi—were significantly more prevalent in the nevus cohort (irregular globules/dots detected in 57% of nevi versus 34% of CM; radial streaks observed in 32% of nevi compared to 16% of CM) [20,21]. This striking overlap highlights the reduced specificity of major melanoma criteria in this anatomical site and quantitatively supports the clinical impression that traditional diagnostic algorithms may perform worse on the trunk. These findings reinforce the notion that truncal lesions display a high degree of phenotypic convergence between benign and malignant patterns, increasing the risk of both false-positive and false-negative interpretations. Our hypothesis theorizes that this difficulty arises not from a unique microanatomy, as seen in “special sites”, but from the trunk’s distinct biomechanical stress. The constant tensile and frictional forces may induce morphologic changes in benign nevi that mimic the dermoscopic features of malignancy, acting as a significant confounder. In interpreting our results from this perspective, we first validated our cohort against previous studies. An age- and sex-adjusted logistic regression analysis demonstrated that established predictors of CM, such as the blue-white veil (OR 5.1) and polymorphous vessels (OR 4.1), retained strong predictive power, consistent with a meta-analysis by Williams et al., which reported ORs of 6.3 and 5.1, respectively [20]. However, in our cohort, scar-like regression was not a statistically significant predictor of CM (OR 1.3; p = 0.1111), a complete contrast to its recognized role as a hallmark of malignancy [22]. This finding is further supported by the lack of significance for the presence of the gray color, a feature histologically linked to regression [23]. From the perspective of our working hypothesis, this anomaly can be explained: chronic microtrauma on the trunk may induce “pseudo-regression”—inflammation, fibrosis, and melanophages—in benign nevi, creating features that are histologically and dermoscopically indistinguishable from true, immune-mediated regression in melanoma [24,25,26,27]. This high prevalence in the benign control group effectively invalidates the feature’s specificity. The most significant and novel finding of this study, however, provides a new lens through which to view these biomechanical interactions. We identified that the lesion’s major axis orientation relative to Langer’s lines is a powerful predictor of malignancy in melanocytic neoplasms. A lesion whose major axis does not follow these lines of skin tension has over five times the odds of being a CM (OR 5.55; 95% CI 3.22–9.81; p < 0.001, adjusted for sex and age). This elevates a previous qualitative observation by McClenahan et al. into a quantified, clinically potent tool [16]. The implications of this finding can be discussed in the broadest context of cell biology and tumor mechanics. Langer’s lines represent the macroscopic manifestation of the dermis’s anisotropic architecture, where collagen fibers are preferentially oriented [28,29]. It is a well-established principle that cell migration is influenced by the topography of the extracellular matrix (ECM), a phenomenon known as “contact guidance” [30]. We propose that the slow, organized proliferation of benign nevus cells is guided by this dermal architecture, causing the lesion to elongate along the path of least mechanical resistance, parallel to Langer’s lines. Malignant melanocytes, conversely, grow in a more chaotic manner. In this state, malignant cells are capable of greater individual motility and active ECM remodeling; therefore, they can grow without adhering to the tissue’s intrinsic architecture, invading in a direction dictated by their own proliferative driver rather than by pre-existing tension lines [31,32]. Therefore, a lesion’s macroscopic orientation becomes a visual proxy for its microscopic biological behavior: alignment signifies adherence to tissue rules (benign), while non-alignment signifies chaotic invasion (malignant). This hypothesis is further corroborated by computational modeling studies. A study by Crisan et al. developed a computational model simulating the growth of melanocytic nevi under mechanical stress [33]. Their model predicted that benign lesions, when subjected to the anisotropic tension characteristic of skin, naturally evolve into an elliptical shape, with their major axis aligning with the direction of principal stress—a finding that provides a compelling theoretical basis for our observation of nevi aligning with Langer’s lines. Furthermore, the model suggested a mechanistic link to malignant progression. As the simulated nevus grows, internal mechanical stress accumulates, particularly at the periphery. The authors proposed that if this stress surpasses a critical threshold, it can induce a loss of cellular cohesion at the border, a physical event that could represent the initial step towards invasion [33]. This concept aligns remarkably well with our finding that CMs disregard these lines of tension, suggesting their growth is driven by an active state that overcomes the passive guidance of the dermal microenvironment. This interplay was further highlighted in our subgroup analysis of “critical” (high-stress) versus “non-critical” (low-stress) truncal sites. While most predictors were consistent, color asymmetry was a significant predictor of CM only in non-critical sites, losing all significance in critical areas (p for interaction = 0.026). This suggests that in high-stress regions, chronic mechanical forces can induce benign pigmentary variegation, rendering color asymmetry an unreliable marker. The clinical implications of these findings are substantial. The Langer’s lines criterion, if validated, could be integrated into diagnostic algorithms, potentially improving accuracy and reducing the NNE for the trunk. However, this study has limitations, including a selection bias inherent in using only excised nevi and the retrospective nature of the analysis, which was not optimized for assessing lesion orientation. These limitations highlight clear future research directions. It is crucial to conduct a multicentric, prospective study with a standardized photographic protocol to validate the Langer’s lines criterion. Furthermore, in vitro studies using anisotropic collagen scaffolds could directly test the contact guidance hypothesis by observing the migration patterns of benign versus malignant melanocytes. In conclusion, this study not only provides data confirming the diagnostic complexity of the trunk but also offers a novel, powerful, and biologically plausible criterion—lesion orientation—that could transform clinical practice for this challenging anatomical site, pending further validation.

5. Conclusions

Our findings indicate that the trunk is a site of significant diagnostic complexity for melanocytic lesions, as demonstrated by an NNE higher than at other anatomical sites (3.6 vs. 2.0). We found that the diagnostic utility of established CM predictors, particularly regression, is attenuated on the trunk, likely due to biomechanical confounding factors that induce pseudo-atypical features in benign nevi. This finding helps explain the clinical challenge and high rate of benign excisions in this location. The most significant contribution of this work is the identification and quantification of a novel and powerful predictor of malignancy: the non-alignment of a lesion with Langer’s skin tension lines. A melanocytic lesion on the trunk that does not follow this orientation has 5.55 times the odds of being a melanoma. This simple, overlooked feature, supported by a robust biomechanical rationale and consistent with computational models of tumor growth, offers a promising tool to improve diagnostic accuracy. Future multicentric prospective studies are essential to validate this finding, which, if confirmed, could be integrated into diagnostic algorithms to facilitate earlier melanoma detection and reduce unnecessary excisions.

Author Contributions

U.S. and F.C. contributed equally to this work and share first authorship. Conceptualization, F.C., U.S., S.R., P.Q. and P.B.; methodology, F.C., U.S. and P.F.; formal analysis, S.D., G.M. and O.C.; investigation, S.D., U.S., F.R., A.A. and F.C.; data curation, S.D. and G.M.; writing—original draft, U.S. and F.C.; writing—review and editing, S.G. and P.F.; supervision, P.F., S.R. and P.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was approved by Comitato Etico Interaziendale (approval number 387; approved on 21 October 2024) and was conducted in accordance with the principles of the declaration of Helsinki.

Informed Consent Statement

All patients in this manuscript have given written informed consent for participation in the study and the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CMCutaneous melanoma
SDStandard deviation
OROdds ratio
NNENumber needed to excise
ECMExtracellular matrix

References

  1. Siegel, R.L.; Miller, K.D.; Wagle, N.S.; Jemal, A. Cancer Statistics, 2023. CA Cancer J. Clin. 2023, 73, 17–48. [Google Scholar] [CrossRef] [PubMed]
  2. Schadendorf, D.; van Akkooi, A.C.J.; Berking, C.; Griewank, K.G.; Gutzmer, R.; Hauschild, A.; Stang, A.; Roesch, A.; Ugurel, S. Melanoma. Lancet 2018, 392, 971–984. [Google Scholar] [CrossRef] [PubMed]
  3. Rosendahl, C.; Tschandl, P.; Cameron, A.; Kittler, H. Diagnostic Accuracy of Dermatoscopy for Melanocytic and Nonmelanocytic Pigmented Lesions. J. Am. Acad. Dermatol. 2011, 64, 1068–1073. [Google Scholar] [CrossRef] [PubMed]
  4. Vestergaard, M.E.; Macaskill, P.; Holt, P.E.; Menzies, S.W. Dermoscopy Compared with Naked Eye Examination for the Diagnosis of Primary Melanoma: A Meta-Analysis of Studies Performed in a Clinical Setting. Br. J. Dermatol. 2008, 159, 669–676. [Google Scholar] [CrossRef]
  5. Argenziano, G.; Fabbrocini, G.; Carli, P.; De Giorgi, V.; Sammarco, E.; Delfino, M. Epiluminescence Microscopy for the Diagnosis of Doubtful Melanocytic Skin Lesions. Comparison of the ABCD Rule of Dermatoscopy and a New 7-Point Checklist Based on Pattern Analysis. Arch. Dermatol. 1998, 134, 1563–1570. [Google Scholar] [CrossRef]
  6. Nelson, K.C.; Swetter, S.M.; Saboda, K.; Chen, S.C.; Curiel-Lewandrowski, C. Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2019, 155, 1167–1174. [Google Scholar] [CrossRef]
  7. Petty, A.J.; Ackerson, B.; Garza, R.; Peterson, M.; Liu, B.; Green, C.; Pavlis, M. Meta-Analysis of Number Needed to Treat for Diagnosis of Melanoma by Clinical Setting. J. Am. Acad. Dermatol. 2020, 82, 1158–1165. [Google Scholar] [CrossRef]
  8. Lallas, A.; Paschou, E.; Manoli, S.-M.; Papageorgiou, C.; Spyridis, I.; Liopyris, K.; Bobos, M.; Moutsoudis, A.; Lazaridou, E.; Apalla, Z. Dermatoscopy of Melanoma According to Type, Anatomic Site and Stage. Ital. J. Dermatol. Venerol. 2021, 156, 274–288. [Google Scholar] [CrossRef]
  9. Longo, C.; Pampena, R.; Moscarella, E.; Chester, J.; Starace, M.; Cinotti, E.; Piraccini, B.M.; Argenziano, G.; Peris, K.; Pellacani, G. Dermoscopy of Melanoma According to Different Body Sites: Head and Neck, Trunk, Limbs, Nail, Mucosal and Acral. J. Eur. Acad. Dermatol. Venereol. 2023, 37, 1718–1730. [Google Scholar] [CrossRef]
  10. Whiteman, D.C.; Green, A.C.; Olsen, C.M. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031. J. Investig. Dermatol. 2016, 136, 1161–1171. [Google Scholar] [CrossRef]
  11. Cavallo, F.; Santaniello, U.; Bin, E.; Roccuzzo, G.; Giordano, S.; Agostini, A.; Merli, M.; Fava, P.; Quaglino, P.; Ribero, S.; et al. Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study on 285 Patients. Cancers 2025, 17, 2597. [Google Scholar] [CrossRef]
  12. Sclerosing Melanocytic Lesions (Sclerosing Melanomas with Nevoid Features and Sclerosing Nevi with Pseudomelanomatous Features)—An Analysis of 90 Lesions—PMC. Available online: https://pmc.ncbi.nlm.nih.gov/articles/PMC6043882/ (accessed on 14 August 2025).
  13. Hassanein, A.; Depick-Smith, N.; Magill, M.; Bandarchi, B. Focal Regression-Like Changes in Dysplastic Back Nevi: A Diagnostic Pitfall for Malignant Melanoma. Hassanein. J. Cutan. Pathol. 2005, 32, 91. [Google Scholar] [CrossRef]
  14. Borges, A.F. Relaxed Skin Tension Lines (RSTL) versus Other Skin Lines. Plast. Reconstr. Surg. 1984, 73, 144–150. [Google Scholar] [CrossRef] [PubMed]
  15. Langer, K. On the Anatomy and Physiology of the Skin. I. The Cleavability of the Cutis. Br. J. Plast. Surg. 1978, 31, 3–8. [Google Scholar]
  16. McClenahan, P.; Blake, T.; Douglas, N.; Gilmore, S.; Soyer, H.P. Quantifying the Orientation of Acquired Melanocytic Nevi on the Back. Arch. Dermatol. 2012, 148, 857–859. [Google Scholar] [CrossRef][Green Version]
  17. Argenziano, G.; Soyer, H.P.; Chimenti, S.; Talamini, R.; Corona, R.; Sera, F.; Binder, M.; Cerroni, L.; De Rosa, G.; Ferrara, G.; et al. Dermoscopy of Pigmented Skin Lesions: Results of a Consensus Meeting via the Internet. J. Am. Acad. Dermatol. 2003, 48, 679–693. [Google Scholar] [CrossRef] [PubMed]
  18. Thomas, L.; Puig, S. Dermoscopy, Digital Dermoscopy and Other Diagnostic Tools in the Early Detection of Melanoma and Follow-up of High-Risk Skin Cancer Patients. Acta Derm. Venereol. 2017, 97 (Suppl. S218), 14–21. [Google Scholar] [CrossRef]
  19. Marghoob, N.G.; Liopyris, K.; Jaimes, N. Dermoscopy: A Review of the Structures That Facilitate Melanoma Detection. J. Osteopath. Med. 2019, 119, 380–390. [Google Scholar] [CrossRef]
  20. Williams, N.M.; Rojas, K.D.; Reynolds, J.M.; Kwon, D.; Shum-Tien, J.; Jaimes, N. Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection. JAMA Dermatol. 2021, 157, 1–12. [Google Scholar] [CrossRef]
  21. Schweizer, A.; Fink, C.; Bertlich, I.; Toberer, F.; Mitteldorf, C.; Stolz, W.; Enk, A.; Kilian, S.; Haenssle, H.A. Differentiation of Combined Nevi and Melanomas: Case-Control Study with Comparative Analysis of Dermoscopic Features. JDDG J. Der Dtsch. Dermatol. Ges. 2020, 18, 111–118. [Google Scholar] [CrossRef]
  22. Carrera, C.; Marchetti, M.A.; Dusza, S.W.; Argenziano, G.; Braun, R.P.; Halpern, A.C.; Jaimes, N.; Kittler, H.J.; Malvehy, J.; Menzies, S.W.; et al. Validity and Reliability of Dermoscopic Criteria Used to Differentiate Nevi From Melanoma: A Web-Based International Dermoscopy Society Study. JAMA Dermatol. 2016, 152, 798–806. [Google Scholar] [CrossRef]
  23. Seidenari, S.; Ferrari, C.; Borsari, S.; Benati, E.; Ponti, G.; Bassoli, S.; Giusti, F.; Schianchi, S.; Pellacani, G. Reticular Grey-Blue Areas of Regression as a Dermoscopic Marker of Melanoma in Situ. Br. J. Dermatol. 2010, 163, 302–309. [Google Scholar] [CrossRef] [PubMed]
  24. Osella-Abate, S.; Conti, L.; Annaratone, L.; Senetta, R.; Bertero, L.; Licciardello, M.; Caliendo, V.; Picciotto, F.; Quaglino, P.; Cassoni, P.; et al. Phenotypic Characterisation of Immune Cells Associated with Histological Regression in Cutaneous Melanoma. Pathology 2019, 51, 487–493. [Google Scholar] [CrossRef]
  25. Blessing, K.; McLaren, K.M. Histological Regression in Primary Cutaneous Melanoma: Recognition, Prevalence and Significance. Histopathology 1992, 20, 315–322. [Google Scholar] [CrossRef]
  26. Ribero, S.; Moscarella, E.; Ferrara, G.; Piana, S.; Argenziano, G.; Longo, C. Regression in Cutaneous Melanoma: A Comprehensive Review from Diagnosis to Prognosis. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 2030–2037. [Google Scholar] [CrossRef]
  27. Selim, M.A.; Vollmer, R.T.; Herman, C.M.; Pham, T.T.N.; Turner, J.W. Melanocytic Nevi with Nonsurgical Trauma: A Histopathologic Study. Am. J. Dermatopathol. 2007, 29, 134–136. [Google Scholar] [CrossRef]
  28. Verhaegen, P.D.H.M.; Res, E.M.; van Engelen, A.; Middelkoop, E.; van Zuijlen, P.P.M. A Reliable, Non-Invasive Measurement Tool for Anisotropy in Normal Skin and Scar Tissue. Skin Res. Technol. 2010, 16, 325–331. [Google Scholar] [CrossRef] [PubMed]
  29. Elouneg, A.; Chambert, J.; Lejeune, A.; Lucot, Q.; Jacquet, E.; Bordas, S.P.A. Anisotropic Mechanical Characterization of Human Skin by in Vivo Multi-Axial Ring Suction Test. J. Mech. Behav. Biomed. Mater. 2023, 141, 105779. [Google Scholar] [CrossRef]
  30. Provenzano, P.P.; Inman, D.R.; Eliceiri, K.W.; Trier, S.M.; Keely, P.J. Contact Guidance Mediated Three-Dimensional Cell Migration Is Regulated by Rho/ROCK-Dependent Matrix Reorganization. Biophys. J. 2008, 95, 5374–5384. [Google Scholar] [CrossRef]
  31. Friedl, P.; Alexander, S. Cancer Invasion and the Microenvironment: Plasticity and Reciprocity. Cell 2011, 147, 992–1009. [Google Scholar] [CrossRef] [PubMed]
  32. Winkler, J.; Abisoye-Ogunniyan, A.; Metcalf, K.J.; Werb, Z. Concepts of Extracellular Matrix Remodelling in Tumour Progression and Metastasis. Nat. Commun. 2020, 11, 5120. [Google Scholar] [CrossRef] [PubMed]
  33. Taloni, A.; Alemi, A.A.; Ciusani, E.; Sethna, J.P.; Zapperi, S.; Porta, C.A.M.L. Mechanical Properties of Growing Melanocytic Nevi and the Progression to Melanoma. PLoS ONE 2014, 9, e94229. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The original map of skin tension lines (cleavage lines) as illustrated by Karl Langer. The image is from Langer’s 1861 publication and is in the public domain. (Source: Langer, K. (1861). Zur Anatomie und Physiologie der Haut. I. Über die Spaltbarkeit der Cutis. Sitzungsberichte der Kaiserlichen Akademie der Wissenschaften, Mathematisch-Naturwissenschaftliche Classe, 44, 19.) [15].
Figure 1. The original map of skin tension lines (cleavage lines) as illustrated by Karl Langer. The image is from Langer’s 1861 publication and is in the public domain. (Source: Langer, K. (1861). Zur Anatomie und Physiologie der Haut. I. Über die Spaltbarkeit der Cutis. Sitzungsberichte der Kaiserlichen Akademie der Wissenschaften, Mathematisch-Naturwissenschaftliche Classe, 44, 19.) [15].
Cancers 17 03064 g001
Figure 2. (A) A flank nevus with gray color and inverse network at dermoscopy that follow Langer’s lines; (B) a CM showing a growth pattern that does not respect skin tension lines (cleavage lines) as illustrated by Karl Langer.
Figure 2. (A) A flank nevus with gray color and inverse network at dermoscopy that follow Langer’s lines; (B) a CM showing a growth pattern that does not respect skin tension lines (cleavage lines) as illustrated by Karl Langer.
Cancers 17 03064 g002
Table 1. Anatomical site/area of excised lesions on the trunk.
Table 1. Anatomical site/area of excised lesions on the trunk.
Site/AreaNevi, n (%)CM, n (%)
Interscapular39 (17.2%)14 (14.9%)
Scapular43 (18.9%)16 (17.0%)
Pectoral22 (9.7%)10 (10.6%)
Sternal/Parasternal7 (3.1%)9 (9.6%)
Dorsal29 (12.8%)13 (13.8%)
Lumbar27 (11.9%)7 (7.4%)
Abdomen38 (16.7%)16 (17.0%)
Flank13 (5.7%)5 (5.3%)
Shoulder9 (4.0%)4 (4.3%)
Total227 (100%)94 (100%)
Table 2. Frequency of dermoscopic features and adherence to Langer’s lines in truncal nevi versus melanomas.
Table 2. Frequency of dermoscopic features and adherence to Langer’s lines in truncal nevi versus melanomas.
ParameterNevi, n (%)CM, n (%)p-Value
Asymmetry of pattern107 (47%)60 (64%)0.0052
Asymmetry of color120 (53%)58 (62%)0.1911
Atypical blotches23 (10%)21 (22%)<0.01
Blue-white veil11 (5%)21 (22%)<0.01
Hypopigmented structureless areas145 (64%)80 (85%)<0.01
Atypical network145 (64%)74 (79%)0.0114
Regression (scar-like)34 (15%)21 (22%)0.1111
Peppering48 (21%)33 (35%)<0.01
Irregular globules/dots130 (57%)32 (34%)<0.01
Pseudopods11 (5%)1 (1%)0.1041
Radial streaks73 (32%)15 (16%)<0.01
Polymorphous vessels11 (5%)14 (15%)<0.01
Shiny white lines16 (7%)11 (12%)0.1279
Angulated lines5 (2%)11 (12%)<0.01
Inverse network14 (6%)6 (6%)0.9420
Prominent skin markings2 (1%)2 (2%)0.5956
Gray color102 (45%)47 (50%)0.4497
Globular pattern52 (23%)4 (4%)<0.01
Reticular pattern132 (58%)42 (45%)0.0228
Homogeneous pattern20 (9%)4 (4%)0.1579
Multicomponent pattern66 (29%)46 (49%)<0.01
Non-adherence to Langer’s lines64 (28%)66 (70%)<0.01
Statistical analysis performed using the chi-square (χ2) test. Statistically significant values (p < 0.05) are bolded highlighted.
Table 3. Age- and sex-adjusted logistic regression analysis of dermoscopic predictors for truncal melanoma.
Table 3. Age- and sex-adjusted logistic regression analysis of dermoscopic predictors for truncal melanoma.
ParameterOdds Ratio (OR)95% Confidence Interval (CI)p-Value
Predictors of Melanoma (OR > 1)
Non-Adherence to Langer’s Lines5.553.22–9.81<0.001
Angulated Lines5.241.56–20.970.07
Blue-White Veil5.092.26–12.04<0.001
Polymorphous Vessels4.061.67–10.190.02
Hypopigmented Structureless Areas3.051.61–6.13<0.001
Atypical Blotches2.351.16–4.760.18
Multicomponent Pattern2.011.18–3.420.10
Peppering2.301.07–3.370.29
Atypical Network2.241.03–3.410.40
Predictors of Nevi (OR < 1)
Globular Pattern0.240.07–0.630.04
Radial Streaks0.410.21–0.770.06
Irregular Globules/Dots0.460.27–0.780.04
Odds ratios are adjusted for patient age and sex. Variables with fewer than 10 cases (e.g., pseudopods, documented growth) were excluded from the regression model. Statistically significant values (p < 0.05) are highlighted.
Table 4. Subgroup logistic regression analysis of dermoscopic predictors by anatomic site.
Table 4. Subgroup logistic regression analysis of dermoscopic predictors by anatomic site.
ParameterNon-Critical Sites, OR (95%CI)Critical Sites OR (95%CI)p for Interaction
Non-Adherence to Langer’s Lines6.04 (2.72–14.14)5.29 (2.43–12.16)0.958
Hypopigmented structureless areas2.19 (0.96–5.33)5.15 (1.76–19.16)0.461
Blue-White Veil3.67 (1.00–14.72)6.44 (2.21–20.78)0.415
Asymmetry of Color2.27 (1.06–5.02)0.63 (0.29–1.35)0.026
Atypical Network2.81 (1.15–7.70)1.44 (0.65–3.35)0.240
Multicomponent Pattern1.35 (0.60–2.97)2.60 (1.23–5.57)0.379
Radial Streaks0.68 (0.29–1.55)0.16 (0.04–0.48)0.097
Globular Pattern0.32 (0.05–1.27)0.20 (0.03–0.78)0.944
Odds ratios are adjusted for patient age and sex. Only key variables are shown for brevity. Statistically significant interactions (p < 0.05) are highlighted.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Santaniello, U.; Cavallo, F.; Diana, S.; Giordano, S.; Crespi, O.; Rosset, F.; Agostini, A.; Moirano, G.; Fava, P.; Quaglino, P.; et al. Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk. Cancers 2025, 17, 3064. https://doi.org/10.3390/cancers17183064

AMA Style

Santaniello U, Cavallo F, Diana S, Giordano S, Crespi O, Rosset F, Agostini A, Moirano G, Fava P, Quaglino P, et al. Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk. Cancers. 2025; 17(18):3064. https://doi.org/10.3390/cancers17183064

Chicago/Turabian Style

Santaniello, Umberto, Francesco Cavallo, Sara Diana, Silvia Giordano, Orsola Crespi, François Rosset, Andrea Agostini, Giovenale Moirano, Paolo Fava, Pietro Quaglino, and et al. 2025. "Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk" Cancers 17, no. 18: 3064. https://doi.org/10.3390/cancers17183064

APA Style

Santaniello, U., Cavallo, F., Diana, S., Giordano, S., Crespi, O., Rosset, F., Agostini, A., Moirano, G., Fava, P., Quaglino, P., Ribero, S., & Broganelli, P. (2025). Melanoma Clues Beyond Dermoscopic Patterns: Lesion Orientation to Langer’s Lines as a Predictor on the Trunk. Cancers, 17(18), 3064. https://doi.org/10.3390/cancers17183064

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop